256 related articles for article (PubMed ID: 29461055)
1. Bidirectional Degradation of DNA Cleavage Products Catalyzed by CRISPR/Cas9.
Stephenson AA; Raper AT; Suo Z
J Am Chem Soc; 2018 Mar; 140(10):3743-3750. PubMed ID: 29461055
[TBL] [Abstract][Full Text] [Related]
2. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
[TBL] [Abstract][Full Text] [Related]
3. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
[TBL] [Abstract][Full Text] [Related]
4. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
[TBL] [Abstract][Full Text] [Related]
5. Functional Insights Revealed by the Kinetic Mechanism of CRISPR/Cas9.
Raper AT; Stephenson AA; Suo Z
J Am Chem Soc; 2018 Feb; 140(8):2971-2984. PubMed ID: 29442507
[TBL] [Abstract][Full Text] [Related]
6. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
[TBL] [Abstract][Full Text] [Related]
7. Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
Heler R; Samai P; Modell JW; Weiner C; Goldberg GW; Bikard D; Marraffini LA
Nature; 2015 Mar; 519(7542):199-202. PubMed ID: 25707807
[TBL] [Abstract][Full Text] [Related]
8. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage.
Jiang F; Taylor DW; Chen JS; Kornfeld JE; Zhou K; Thompson AJ; Nogales E; Doudna JA
Science; 2016 Feb; 351(6275):867-71. PubMed ID: 26841432
[TBL] [Abstract][Full Text] [Related]
9. Conformational control of DNA target cleavage by CRISPR-Cas9.
Sternberg SH; LaFrance B; Kaplan M; Doudna JA
Nature; 2015 Nov; 527(7576):110-3. PubMed ID: 26524520
[TBL] [Abstract][Full Text] [Related]
10. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
Karvelis T; Gasiunas G; Siksnys V
Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
[TBL] [Abstract][Full Text] [Related]
11. Cas9-catalyzed DNA Cleavage Generates Staggered Ends: Evidence from Molecular Dynamics Simulations.
Zuo Z; Liu J
Sci Rep; 2016 Nov; 5():37584. PubMed ID: 27874072
[TBL] [Abstract][Full Text] [Related]
12. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a).
Singh D; Mallon J; Poddar A; Wang Y; Tippana R; Yang O; Bailey S; Ha T
Proc Natl Acad Sci U S A; 2018 May; 115(21):5444-5449. PubMed ID: 29735714
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 searches for a protospacer adjacent motif by lateral diffusion.
Globyte V; Lee SH; Bae T; Kim JS; Joo C
EMBO J; 2019 Feb; 38(4):. PubMed ID: 30573670
[TBL] [Abstract][Full Text] [Related]
14. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion.
Shou J; Li J; Liu Y; Wu Q
Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells.
Kim D; Kim J; Hur JK; Been KW; Yoon SH; Kim JS
Nat Biotechnol; 2016 Aug; 34(8):863-8. PubMed ID: 27272384
[TBL] [Abstract][Full Text] [Related]
16. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
17. Structural biology. Cas9, poised for DNA cleavage.
Chen H; Bailey S
Science; 2016 Feb; 351(6275):811-2. PubMed ID: 26912877
[No Abstract] [Full Text] [Related]
18. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA.
Liu MS; Gong S; Yu HH; Jung K; Johnson KA; Taylor DW
Nat Commun; 2020 Jul; 11(1):3576. PubMed ID: 32681021
[TBL] [Abstract][Full Text] [Related]
19. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
[TBL] [Abstract][Full Text] [Related]
20. SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power.
Zhang D; Zhang B
Trends Genet; 2020 Aug; 36(8):546-548. PubMed ID: 32456805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
